About LDI Rx
LDI Rx is a Financial Services company based in St. Louis (United States) founded in 1967, and was acquired by Diplomat in November 2017. Provider of pharmacy benefit managers services. Its chief executive, as recorded, is Brian T Griffin. Its focus areas include Services for Health Insurers and Healthcare.
Company details
Founded in 1967, LDI is based in St. Louis, United States, within the healthcare sector. Pharmacy benefit management services are delivered by the company, including administration of prescription drug programs and cost containment for employers and health plans. Operations emphasize regulatory compliance and network management across the U.S. Leadership is provided by CEO Brian T. Griffin, supporting ongoing service delivery in the industry.
- Investors
- Acquired byDiplomat
(Nov 2017)
Investors in LDI Rx
LDI Rx has secured backing from 1 investor. Prominent investors backing the company include Optum Specialty Pharmacy.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Specialty pharmacy services are provided for complex medical conditions. | 1975 | diplomatpharmacy.com | Flint, United States |
Investor details for LDI Rx
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of LDI Rx
1 people are tracked at LDI Rx (1 in leadership).
| Name | Role | Group |
|---|---|---|
Brian T Griffin | CEO | Leadership |
Complete people profiles for LDI Rx
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of LDI Rx
2 dated milestones of LDI Rx across 50 years, from founding to its latest funding, stage changes and deals.
- Founded LDI Rx is founded.
- Exit Acquired by Diplomat.
Top companies in Insurance & Risk Management
3 companies that operate in the same segment as LDI Rx (Insurance & Risk Management) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Investment advisory, insurance distribution, and risk management services are provided. | 1998 | Chicago, Illinois, United States | USD 1.6 B | |||
Financial institution offering insurance & transaction services | 1847 | Jacksonville, United States | USD 500 M | USD 14.51 B | 23,530 | |
Integrated healthcare services and coverage are provided nationwide. | 1945 | United States |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about LDI Rx
LDI Rx was founded in 1967.
LDI Rx is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.
Brian T Griffin is the CEO of LDI Rx, as recorded in our data.
Founded in 1967, LDI is based in St. Louis, United States, within the healthcare sector. Pharmacy benefit management services are delivered by the company, including administration of prescription drug programs and cost containment for employers and health plans. Operations emphasize regulatory compliance and network management across the U.S. Leadership is provided by CEO Brian T. Griffin, supporting ongoing service delivery in the industry.
LDI Rx has 1 investor. Key investors include Optum Specialty Pharmacy.
Yes. LDI Rx was acquired by Diplomat in November 2017.
